title: Dramatic reduction in tumour size in hepatocellular carcinoma patients on thalidomide therapy.
authors: Department of Gastroenterology, University of Alberta Liver Unit, Edmonton, Canada.
authors: Denny
authors: D
authors: Demeria
authors: Iain
authors: I
authors: Birchall
authors: Vincent G
authors: VG
authors: Bain
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D017809:Fatal Outcome; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D013792:Thalidomide / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide
references: Hepatology. 2002 Sep;36(3):687-91
references: 12198662
references: Cancer Chemother Pharmacol. 2006 Nov;58(5):654-64
references: 16520988
references: Hepatology. 2003 Feb;37(2):429-42
references: 12540794
references: Cancer. 2005 Feb 15;103(4):749-55
references: 15660400
references: Anticancer Drugs. 2004 Jun;15(5):439-52
references: 15166617
references: Biochem Pharmacol. 1998 Jun 1;55(11):1827-34
references: 9714301
references: Oncology. 2003;65(3):242-9
references: 14657598